Cargando…

suPAR and WT1 modify the adhesion of podocytes and are related to proteinuria in class IV lupus nephritis

INTRODUCTION: Lupus nephritis (LN) affects up to 60 % of the patients with Systemic Lupus Erythematosus (SLE) and renal damage progression is associated with proteinuria, caused in part by the integrity of the glomerular basement membrane (GBM) and by podocyte injury. The soluble urokinase plasminog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bollain-y-Goytia, Juan-José, Torres-Del-muro, Felipe-de-Jesús, Hernández-Martínez, Sara-Paola, Avalos-Díaz, Esperanza, Herrera-Esparza, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587709/ https://www.ncbi.nlm.nih.gov/pubmed/37868110 http://dx.doi.org/10.1016/j.jtauto.2023.100216

Ejemplares similares

Increased excretion of urinary podocytes in lupus nephritis
por: Bollain-y-Goytia, J. J., et al.
Publicado: (2011)

SuPAR mediates viral response proteinuria by rapidly changing podocyte function
por: Wei, Changli, et al.
Publicado: (2023)

Soluble Fas and the −670 Polymorphism of Fas in Lupus Nephritis
por: Bollain-y-Goytia, Juan José, et al.
Publicado: (2014)

suPAR and Team Nephrology
por: Trachtman, Howard
Publicado: (2014)

suPAR: The Molecular Crystal Ball
por: Thunø, Maria, et al.
Publicado: (2009)

suPAR: An Inflammatory Mediator for Kidneys
por: Sudhini, Yashwanth Reddy, et al.
Publicado: (2022)

Cytoplasmic Localization of WT1 and Decrease of miRNA-16-1 in Nephrotic Syndrome
por: Zapata-Benavides, Pablo, et al.
Publicado: (2017)

suPAR as a prognostic biomarker in sepsis
por: Donadello, Katia, et al.
Publicado: (2012)

Reassessing the Reassessment of suPAR in Glomerular Disease
por: Meijers, Björn K. I., et al.
Publicado: (2015)

suPAR to Risk-Stratify Patients With Malaria
por: Stefanova, Veselina, et al.
Publicado: (2022)

suPAR, a Circulating Kidney Disease Factor
por: Wei, Changli, et al.
Publicado: (2021)

An Animal Model Using Metallic Ions to Produce Autoimmune Nephritis
por: Ramírez-Sandoval, Roxana, et al.
Publicado: (2015)

Apoptosis and Redistribution of the Ro Autoantigen in Balb/c Mouse Like in Subacute Cutaneous Lupus Erythematosus
por: Herrera-Esparza, Rafael, et al.
Publicado: (2006)

The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine Perspective
por: Benucci, Maurizio, et al.
Publicado: (2022)

SuPAR - A future prognostic biomarker in emergency medicine
por: Østervig, Rebecca M, et al.
Publicado: (2015)

Podocyte Injury in Lupus Nephritis
por: Sakhi, Hamza, et al.
Publicado: (2019)

suPAR remains uninfluenced by surgery in septic patients with bloodstream infection
por: Rabensteiner, Jasmin, et al.
Publicado: (2016)

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis
por: Garnæs, Emilie, et al.
Publicado: (2019)

suPAR Surprises as a Biomarker of Invasive Outcomes in Pleural Infection
por: Idell, Steven, et al.
Publicado: (2020)

The Perspective of Vitamin D on suPAR-Related AKI in COVID-19
por: Liao, Tzu-Hsien, et al.
Publicado: (2022)

The Association of suPAR with Cardiovascular Risk Factors in Young and Healthy Adults
por: Wohlwend, Niklas Fabio, et al.
Publicado: (2023)

Detection of suPAR in the Saliva of Healthy Young Adults: Comparison with Plasma Levels
por: Gustafsson, Anna, et al.
Publicado: (2011)

SuPAR predicts postoperative complications and mortality in patients with asymptomatic aortic stenosis
por: Hodges, Gethin W, et al.
Publicado: (2018)

Plasma levels of the active form of suPAR are associated with COVID-19 severity
por: Huang, Mingxiang, et al.
Publicado: (2020)

suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19
por: Altintas, Izzet, et al.
Publicado: (2021)

Assay-related differences in SuPAR levels: implications for measurement and data interpretation
por: Vasbinder, Alexi, et al.
Publicado: (2022)

Predictive value of suPAR in AKI: a systematic review and meta-analysis
por: Huang, Yan, et al.
Publicado: (2022)

Soluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update
por: Velissaris, Dimitrios, et al.
Publicado: (2022)

The Prognostic Value of suPAR Compared to Other Inflammatory Markers in Patients with Severe Sepsis
por: Gustafsson, Anna, et al.
Publicado: (2012)

Utility of the Plasma Level of suPAR in Monitoring Risk of Mortality during TB Treatment
por: Rabna, Paulo, et al.
Publicado: (2012)

Innate immune response-mediated late increase in SuPAR in multi-trauma patients
por: Timmermans, K, et al.
Publicado: (2013)

Role of suPAR and Lactic Acid in Diagnosing Sepsis and Predicting Mortality in Elderly Patients
por: Khater, Walaa S., et al.
Publicado: (2016)

Healthy lifestyles reduce suPAR and mortality in a Danish general population study
por: Haupt, Thomas Huneck, et al.
Publicado: (2019)

suPAR in the assessment of post intensive care unit prognosis: a pilot study
por: Silvestre, Joana, et al.
Publicado: (2018)

Neutrophils are a main source of circulating suPAR predicting outcome in critical illness
por: Gussen, Hendrik, et al.
Publicado: (2019)

Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions
por: Arnold, David T., et al.
Publicado: (2020)

Association Between Elevated suPAR, a New Biomarker of Inflammation, and Accelerated Aging
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2020)

Kinetics of SuPAR hemoadsorption in critical COVID-19 patients on renal replacement therapy
por: Vicka, Vaidas, et al.
Publicado: (2022)

Detection of Inflammatory Biomarker suPAR in COVID-19 Disease With CHORUS TRIO Instrument
por: Helena, Cerutti, et al.
Publicado: (2023)

Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis
por: Suh, Chang-Hee
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h5as4v1r6rlhsmoavkk9dcpia4